Key terms

About EYEN

Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest EYEN news

Apr 12 11:08am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 11 11:20am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 08 7:07am ET Eyenovia considers strategic alternatives, including possible sale by TipRanks Apr 03 7:06am ET Eyenovia to feature commercial products, Optejet Dispenser at eyecare meetings by TipRanks Mar 20 2:01am ET Eyenovia’s Financial Future in Jeopardy: Reliance on Two FDA-Approved Products Raises Profitability Concerns by TipRanks Mar 19 8:52am ET Eyenovia Inc Presents Updated Corporate Strategy Overview by TipRanks Mar 19 6:26am ET Eyenovia’s Strategic Commercial Synergy and Growth Potential Reinforce Buy Rating by TipRanks Mar 18 4:08pm ET Eyenovia reports Q4 EPS (18c), consensus (17c) by TipRanks Mar 18 8:05am ET Options Volatility and Implied Earnings Moves Today, March 18, 2024 by TipRanks Mar 13 7:28am ET NovaBay, Eyenovia to co-promote prescription ophthalmic products by TipRanks Mar 08 7:45am ET Eyenovia price target lowered to $10 from $15 at Ladenburg by TipRanks Mar 06 6:37am ET Eyenovia’s Strategic Expansion: Dual Product Offering Enhances Market Position by TipRanks Mar 05 8:13am ET Eyenovia congratulates Formosa Pharmaceuticals on FDA approval by TipRanks Jan 26 4:11am ET Eyenovia Unveils Optejet Platform Progress and Pipeline by TipRanks Jan 22 1:10pm ET Analysts Offer Insights on Healthcare Companies: Kinnate Biopharma (KNTE), Relay Therapeutics (RLAY) and Eyenovia (EYEN) by TipRanks

No recent press releases are available for EYEN

EYEN Financials

1-year income & revenue

Key terms

EYEN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

EYEN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming